Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Alpha‐glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD005061.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 18 October 2006see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Metabolic and Endocrine Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Floris A Van de Laar

    Correspondence to: Department of General Practice, 117 HAG, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    [email protected]

    [email protected]

  • Peter LBJ Lucassen

    Department of General Practice and Family Medicine, Radboud University Medical Centre, Nijmegen, Netherlands

  • Reinier P Akkermans

    Department of General Practice, 117 HAG, Radboud University Nijmegen Medical Centre , Nijmegen, Netherlands

  • Eloy H Van de Lisdonk

    Department of General Practice and Family Medicine, Radboud University Medical Centre , Nijmegen, Netherlands

  • Wim JC De Grauw

    Department of General Practice, 117 HAG, Radboud University Nijmegen Medical Centre , Nijmegen, Netherlands

Contributions of authors

FLORIS VAN DE LAAR: Protocol development, searching for trials, abstract assessment for eligibility, quality assessment of trials, data extraction, data entry, data analysis, review development.

PETER LUCASSEN: Protocol development, abstract assessment for eligibility, quality assessment of trials, data extraction, data analysis, review development.

WIM DE GRAUW: Protocol development, data analysis, review development.

REINIER AKKERMANS: (double) data entry, data analysis, review development.

ELOY VAN DE LISDONK: Quality assessment of trials (referee), data analysis, review development.

Sources of support

Internal sources

  • Radboud University Nijmegen Medical Centre, Netherlands.

External sources

  • No sources of support supplied

Declarations of interest

available in

None known.

Acknowledgements

available in

We would like to thank the following people: all authors, investigators and manufacturers who were willing to answer our questions and who provided us with additional data.
Bas Aarts for the translation of the articles from Chinese language, and Leon Bax for the translation of abstracts in the Japanese language.

Version history

Published

Title

Stage

Authors

Version

2018 Dec 28

Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus

Review

Suzanne VL Moelands, Peter LBJ Lucassen, Reinier P Akkermans, Wim JC De Grauw, Floris A Van de Laar

https://doi.org/10.1002/14651858.CD005061.pub3

2006 Oct 18

Alpha‐glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

Review

Floris A Van de Laar, Peter LBJ Lucassen, Reinier P Akkermans, Eloy H Van de Lisdonk, Wim JC De Grauw

https://doi.org/10.1002/14651858.CD005061.pub2

2004 Oct 18

Alpha‐glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose

Protocol

Floris A. Van de Laar, Peter L.B.J. Lucassen, Reinier P Akkermans, Eloy H Van de Lisdonk, Wim JC De Grauw

https://doi.org/10.1002/14651858.CD005061

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.